King Resources, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that King Resources, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $76.9K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $70.3K | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $198.8K | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $385.4K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $77.4K | Jun 24, 2022 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $30.8K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $28.1K | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $128.5K | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $317.4K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $36.8K | Jun 24, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $1.95M | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | ($1.51M) | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | ($1.32M) | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | ($60.2K) | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | ($133.3K) | Jun 24, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($572.7K) | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | ($609.9K) | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | ($1.02M) | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | ($60.2K) | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | ($136.8K) | Jun 24, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $134.0K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $142.4K | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $259.5K | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $59.4K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $95.0K | Jun 24, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($85.6K) | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | ($284.8K) | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | ($180.8K) | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $86.1K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | ($187.1K) | Jun 24, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Mar 31, 2022 | $5.5K | Jun 24, 2022 |
| FY2022 | Mar 31, 2021 | $0 | Jun 24, 2022 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $3.9K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $132.9K | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $1.09M | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $188.1K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $160.6K | Jun 24, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $957.0K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $3.17M | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $2.72M | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $1.92M | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $1.84M | Jun 24, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($953.0K) | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | ($3.03M) | Jul 15, 2025 |
| FY2025 | Mar 31, 2023 | ($1.63M) | Jul 15, 2025 |
| FY2024 | Mar 31, 2022 | ($1.73M) | Jul 16, 2024 |
| FY2023 | Mar 31, 2021 | ($1.68M) | Jul 14, 2023 |
| FY2022 | Mar 31, 2020 | ($1.56M) | Jun 24, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | ($7.44M) | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | ($9.39M) | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | ($7.88M) | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | ($6.57M) | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | ($6.51M) | Jun 24, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | $2.4K | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | $1.6K | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | $4.9K | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | $14.9K | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | $42.5K | Jun 24, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Jun 24, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 0 | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | 0 | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | 0 | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | 0 | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | 0 | Jun 24, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Mar 31, 2025 | 6.65B | Jul 15, 2025 |
| FY2025 | Mar 31, 2024 | 5.63B | Jul 15, 2025 |
| FY2024 | Mar 31, 2023 | 5.48B | Jul 16, 2024 |
| FY2023 | Mar 31, 2022 | 4.81B | Jul 14, 2023 |
| FY2022 | Mar 31, 2021 | 4.81B | Jun 24, 2022 |